Inhibition by amiloride of experimental carcinogenesis induced by AZASERINE (cas 115-02-6) in rat pancreas

Add time:08/25/2019    Source:sciencedirect.com

The effects of prolonged administration of the diuretic amiloride on pancreatic carcinogenesis induced by AZASERINE (cas 115-02-6) and on the labeling index of carcinogen-induced pancreatic lesions were investigated in Wistar rats. Rats were given 25 weekly injections of 10 mg/kg body weight azaserine and also 5 mg/kg body weight amiloride every other day until the end of the experiment at week 62. Carcinogen-induced pancreatic lesions were examined by histochemical techniques and were classified as ATPase-positive or ATPase-negative. In week 62, quantitative histologic analysis showed that prolonged administration of amiloride significantly reduced the number and size (as percent of parenchyma) of ATPase-positive pancreatic lesions, which are closely correlated with the subsequent development of pancreatic cancer. Amiloride also significantly decreased the labeling index of carcinogen-induced pancreatic lesions, but not of the surrounding acinar cells. In contrast, amiloride has no significant influence on the number and size of ATPase-negative pancreatic lesions. These findings indicate that amiloride inhibits pancreatic carcinogenesis, and that this effect may be related to the reduction of ATPase-positive lesions and to amiloride's inhibition of cell proliferation in neoplastic lesions of the pancreas.

We also recommend Trading Suppliers and Manufacturers of AZASERINE (cas 115-02-6). Pls Click Website Link as below: cas 115-02-6 suppliers

Prev:The specificity of methionine sulfoximine and AZASERINE (cas 115-02-6) inhibition in plant tissuesIn honour of Professor G. H. Neil Towers 75th birthday
Next:Crystal Structures of Escherichia coli γ-Glutamyltranspeptidase in Complex with AZASERINE (cas 115-02-6) and Acivicin: Novel Mechanistic Implication for Inhibition by Glutamine Antagonists)